At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Rapamycin target-eluting Coronary Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Initial Small-Scale Clinical Study of Rapamycin-Eluting Coronary Stent System of Microport (Firehawk)
Shanghai MicroPort Medical (Group) Co., Ltd.·interventional·Posted Feb 23, 2016·Updated Oct 17, 2019
In Brief
A clinical study evaluating Rapamycin target-eluting Coronary Stent System for Coronary Heart Disease. Completed, enrolled 21 participants.
Detailed Summary
This is a small-scale pilot clinical study of the Rapamycin-Eluting Coronary Stent System of Microport for the first time to assess the preliminary safety and feasibility used in the human body. And provide evidence for subsequent large-scale, multi-center, randomized controlled clinical trials, then provide the basis for the formal application of the product in China.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Heart Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2009
Primary CompletionJan 2010
Study CompletionJan 2015
First PostedFeb 2016
TodayJul 2026
First PostedFeb 23, 2016
Enrollment StartDec 1, 2009
Primary CompletionJan 1, 2010
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.4 years ago
Interventions
Rapamycin target-eluting Coronary Stent Systemdevice
Implantation of the rapamycin-eluting coronary stent system